USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP”

USPTO PatentsView assignee record - 12 granted patents across 22 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Obschestvo ranks #23,118 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 22 technology areas.

#23,118
of 49,997 US assignees by volume
Top 47%
by Innovation Score (36.1/100)
11.1
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23118 · Foreign Corporation #23,118 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,118/49,997
  • PHOTO-FINISH NuLabel
  • CPC-FOCUS A61P · 22 areas
  • INNOV-THIN 36.1/100
  • CLAIMS-PAR 11.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: NuLabel Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Obschestvo’s 36.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Obschestvo

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Obschestvo's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Obschestvo?

Each dot is one of Obschestvo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Obschestvo’s own 11.1 claims/patent is at or below the 13.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Obschestvo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 510152025 Granted patents (volume) Avg claims / patent NuLabel Technologies, Inc. - 12, 18.08NulabelNumab Therapeutics AG - 12, 17.42Numab TherapeuticsNura Holdings Pty Ltd - 12, 22.67Nura Holdings PtyNxera Pharma UK Limited - 12, 18Nxera Pharma UKOCM Inc. - 12, 6.83OCMOfficine Maccaferri S.P.A. - 12, 12.25Officine Maccafer…Oleon NV - 12, 13.58OleonOmnimax International, LLC - 12, 9.58Omnimax Internati…Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” - 12, 11.08Obschestvo S Ogra…
Obschestvo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Obschestvo's grants concentrate

Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” is a focused PatentsView assignee: 22 CPC subclasses with 25% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2016. By volume, Obschestvo sits between NuLabel Technologies, Inc. and Omnimax International, LLC.

Obschestvo's three-year grant acceleration

Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Obschestvo's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Obschestvo holds 12 patents at rank #23,110, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Obschestvo

By rank, the assignees closest to #23,110 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Obschestvo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Obschestvo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Obschestvo ranks #4,499 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Obschestvo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2016201720182019202020222024 2
USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 8.3%
2017 2 16.7%
2018 1 8.3%
2019 2 16.7%
2020 3 25.0%
2022 1 8.3%
2024 2 16.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP”'s patent record in context - here's where to go next.

  • Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP”'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 25% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #23,118 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” against NuLabel Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.